Cel Sci Corporation (CVM)

[staticmirror79]

So Fosco asked a good question on StockTwits.

Does anyone have an idea how many of the 928 enrolled patients are still evaluable? Because that would make a big difference in event numbers if we lost a bunch.

I would assume someone dying from an unrelated cause like a car crash would disqualify them from being counted towards either arm of the study since their death had nothing to do with cancer. I also assume there are other factors that could make some unevaluable.

Can anyone shed some light on this?

As far as I see it, if we are still close to 928 patients that can be evaluated we are still looking very good.